GlobeImmune, Inc. (GBIM)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Feb 13, 2026

GlobeImmune Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2015 FY 2014 FY 2013 FY 2012 FY 2011 2010 - 2009
Period Ending
Feb '26 Dec '15 Dec '14 Dec '13 Dec '12 Dec '11 2010 - 2009
Market Capitalization
02244---
Upgrade
Market Cap Growth
-100.00%-48.99%----
Upgrade
Enterprise Value
-1125---
Upgrade
Last Close Price
0.003.877.59---
Upgrade
PS Ratio
-3.457.31---
Upgrade
PB Ratio
-7.457.79---
Upgrade
P/TBV Ratio
-7.457.79---
Upgrade
EV/Sales Ratio
-1.704.15---
Upgrade
Debt / Equity Ratio
----0.02--
Upgrade
Debt / EBITDA Ratio
---0.02--
Upgrade
Debt / FCF Ratio
---0.05--
Upgrade
Net Debt / Equity Ratio
-4.04-3.31-3.000.540.110.94
Upgrade
Net Debt / EBITDA Ratio
4.483.843.04-0.680.661.30
Upgrade
Net Debt / FCF Ratio
1.471.381.63-1.460.152.95
Upgrade
Asset Turnover
0.490.430.463.861.330.25
Upgrade
Quick Ratio
2.102.343.250.920.241.13
Upgrade
Current Ratio
2.282.633.441.060.351.16
Upgrade
Return on Equity (ROE)
-66.24%-64.41%----
Upgrade
Return on Assets (ROA)
-10.26%-11.58%-28.21%82.42%-22.55%-38.01%
Upgrade
Return on Capital Employed (ROCE)
-36.80%-38.00%-44.10%766.10%96.50%-292.70%
Upgrade
Earnings Yield
-34476416.67%-12.43%-37.27%---
Upgrade
FCF Yield
-98611650.00%-32.19%-23.71%---
Upgrade
Buyback Yield / Dilution
-32.85%-97.33%-3050.27%-3.52%-1.74%-2.52%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.